ID.1
Item
type 1 diabetes for more than 12 months
boolean
ID.2
Item
current treatment: basal-bolus insulin regimen for more than three months (i.e. at least one daily injection of long-acting insulin (including insulin glargine) and fast-acting insulin with each main meal)
boolean
C0557978 (UMLS CUI [1])
ID.3
Item
hba1c (glycosylated haemoglobin a1c) between 7.0 and 11.0%
boolean
C0019018 (UMLS CUI [1])
ID.4
Item
able and willing to maintain consistent physical activity level throughout the entire study period
boolean
C0015259 (UMLS CUI [1])
ID.5
Item
able and willing to maintain consistent eating habits throughout the entire study period
boolean
C1266864 (UMLS CUI [1])
ID.6
Item
proliferative retinopathy that has required acute treatment within the last six months
boolean
C0339467 (UMLS CUI [1])
ID.7
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness as judged by the investigator
boolean
C0150254 (UMLS CUI [1])
ID.8
Item
liver, kidney or heart problems as judged by the investigator
boolean
C0012634 (UMLS CUI [1])
ID.9
Item
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0009862 (UMLS CUI [1,3])
ID.10
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1])
ID.11
Item
receipt of any investigational drug within one month prior to this trial
boolean
C0013230 (UMLS CUI [1])